S095024

S095024 is a humanized IgG1 monoclonal antibody inhibitor targeting CD73. S095024 can be used to study acute respiratory distress syndrome (ARDS), non-small cell lung cancer (NSCLC) and advanced solid tumor malignancies[1][2].

Product Specifications

Product Name Alternative

Sym024

UNSPSC

12352203

Target

CD73

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Inflammation/Immunology

References & Citations

[1]Spreafico A, et al. Molecular and early clinical characterization of the anti-CD73 antibody S095024 (Sym024) [J]. Cancer Research, 2024, 84 (6_Supplement) : 3737-3737. |[2]GRANDAL, M M, et al. Anti-cd73 antibodies and compositions. US20210070876A1. 2023-04-25.